Colorectal cancer biomarker
KRAS and BRAF in colorectal cancer: results to prepare before discussing treatment
KRAS, NRAS, and BRAF results help put colorectal cancer treatment options in context. Interpretation still depends on the sample, disease sites, and treatment history.
This may be relevant if
- A tumour report mentions KRAS, NRAS, or BRAF.
- You are discussing targeted therapy after diagnosis or progression.
- The molecular results are incomplete or need to be read with other reports.
What information matters?
Start with what you have. Missing information can be marked and completed later.
- KRAS, NRAS, and BRAF status and testing method
- Disease sites and stage
- Chemotherapy or targeted therapy history
- MSI/MMR, HER2, and other results if available
A practical next step
- 1Add molecular results and pathology reports to the Cancer Passport.
- 2Mark results that are missing or conflicting.
- 3Use the summary when discussing treatment, trials, or a second opinion.
Not a diagnosis and not final medical advice. Must be reviewed by a doctor.
Organise KRAS/BRAF results in your Cancer Passport
Keep molecular results with disease sites and prior treatment so a review does not start from zero.
After submission, a human navigator reviews your request and contacts you through your chosen channel. The WhatsApp message already includes this page context, so you do not need to explain from the beginning.
Clinical data is not requested in the form and is not sent to analytics. Do not send medical reports through WhatsApp or email; use the secure upload page. We do not promise eligibility or any treatment outcome.
Use a case summary, not a copied medical history
The Cancer Passport keeps the information you choose to save in one place so a later review can start from the same context.
Ready to take the next step?
Start with the information you have. A navigator can help identify what to review next.
Prepare for your next consultation
Use the free six-question tool to prepare questions for your doctor.